These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Children's Oncology Group's 2023 blueprint for research: Non-Hodgkin lymphoma. El-Mallawany NK; Alexander S; Fluchel M; Hayashi RJ; Lowe EJ; Giulino-Roth L; Wistinghausen B; Hermiston M; Allen CE; Pediatr Blood Cancer; 2023 Sep; 70 Suppl 6(Suppl 6):e30565. PubMed ID: 37449925 [TBL] [Abstract][Full Text] [Related]
3. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia. Plosker GL; Figgitt DP Drugs; 2003; 63(8):803-43. PubMed ID: 12662126 [TBL] [Abstract][Full Text] [Related]
9. Current approaches to the management of pediatric Hodgkin lymphoma. Freed J; Kelly KM Paediatr Drugs; 2010 Apr; 12(2):85-98. PubMed ID: 20218745 [TBL] [Abstract][Full Text] [Related]
12. [Non-Hodgkin lymphoma: Excellent results at the expense of the high toxicity of the treatment]. Baena-Gómez MA; Mora Matilla M; Lassaletta Atienza A; Andión Catalán M; Hernández Marqués C; Madero López L An Pediatr (Barc); 2015 Jun; 82(6):381-7. PubMed ID: 25446790 [TBL] [Abstract][Full Text] [Related]
13. Comparison of long-term outcome of children and adolescents with disseminated non-lymphoblastic non-Hodgkin lymphoma treated with COMP or daunomycin-COMP: A report from the Children's Cancer Group. Sposto R; Meadows AT; Chilcote RR; Steinherz PG; Kjeldsberg C; Kadin ME; Krailo MD; Termuhlen AM; Morse M; Siegel SE Med Pediatr Oncol; 2001 Nov; 37(5):432-41. PubMed ID: 11745871 [TBL] [Abstract][Full Text] [Related]
14. Targeting non-Hodgkin lymphoma with blinatumomab. Sanders S; Stewart DA Expert Opin Biol Ther; 2017 Aug; 17(8):1013-1017. PubMed ID: 28532177 [TBL] [Abstract][Full Text] [Related]
15. [Recent advances in pediatric non-Hodgkin lymphoma. Report on a retrospective single-center cohort and review of the literature]. Szegedi I; Gáspár I; Gyurina K; Zele Z; Kiss C Magy Onkol; 2018 Dec; 62(4):204-213. PubMed ID: 30540862 [TBL] [Abstract][Full Text] [Related]
16. Children's Oncology Group's 2013 blueprint for research: cancer control and supportive care. Sung L; Zaoutis T; Ullrich NJ; Johnston D; Dupuis L; Ladas E; Pediatr Blood Cancer; 2013 Jun; 60(6):1027-30. PubMed ID: 23255159 [TBL] [Abstract][Full Text] [Related]
17. Novel biologic agents for non-Hodgkin lymphoma and chronic lymphocytic leukemia-part 2: adoptive cellular immunotherapy, small-molecule inhibitors, and immunomodulation. Siddiqi T; Rosen ST Oncology (Williston Park); 2015 Apr; 29(4):299-308. PubMed ID: 25920929 [TBL] [Abstract][Full Text] [Related]